Annexin A5 as an immune checkpoint inhibitor and tumor-homing molecule for cancer treatment
Open Access
- 28 February 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Communications
- Vol. 11 (1), 1-16
- https://doi.org/10.1038/s41467-020-14821-z
Abstract
The interaction between immune cells and phosphatidylserine (PS) molecules exposed on the surface of apoptotic-tumor bodies, such as those induced by chemotherapies, contributes to the formation of an immunosuppressive tumor microenvironment (TME). Annexin A5 (AnxA5) binds with high affinity to PS externalized by apoptotic cells, thereby hindering their interaction with immune cells. Here, we show that AnxA5 administration rescue the immunosuppressive state of the TME induced by chemotherapy. Due to the preferential homing of AnxA5 to the TME enriched with PS+ tumor cells, we demonstrate in vivo that fusing tumor-antigen peptide to AnxA5 significantly enhances its immunogenicity and antitumor efficacy when administered after chemotherapy. Also, the therapeutic antitumor effect of an AnxA5-peptide fusion can be further enhanced by administration of other immune checkpoint inhibitors. Our findings support the administration of AnxA5 following chemotherapy as a promising immune checkpoint inhibitor for cancer treatment.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2013R1A4A1069575)
- Ministry of Health and Welfare (HI15C2524)
- U.S. Department of Health & Human Services | NIH | National Cancer Institute (NIH/NCI P50CA098252)
This publication has 64 references indexed in Scilit:
- Targeted Coating With Antigenic Peptide Renders Tumor Cells Susceptible to CD8+ T Cell-mediated KillingMolecular Therapy, 2013
- The secret ally: immunostimulation by anticancer drugsNature Reviews Drug Discovery, 2012
- Strategies for extended serum half-life of protein therapeuticsCurrent Opinion in Biotechnology, 2011
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Immune responses to malignanciesJournal of Allergy and Clinical Immunology, 2010
- Phospholipids: Key Players in Apoptosis and Immune RegulationMolecules, 2009
- Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hostsCancer Immunology, Immunotherapy, 2008
- Immunological aspects of cancer chemotherapyNature Reviews Immunology, 2008
- Enrolling Women into HIV Preventive Vaccine Trials: An Ethical Imperative but a Logistical ChallengePLoS Medicine, 2006
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002